MasterClass: Flares in Pre-Surgical Patients -

Name: MasterClass: Flares in Pre-Surgical Patients
Uploaded: 2022-01-10T05:00:00+00:00
Duration: 13 min 32 s
Description: In this MasterClass, Dr. Elizabeth Yeu explains how to look for and manage dry eye disease (DED) in pre-surgical patients, such as pre-laser vision correct

Overview
In this MasterClass, Dr. Elizabeth Yeu explains how to look for and manage dry eye disease (DED) in pre-surgical patients, such as pre-laser vision correction and cataract surgery patients. By the end of this course, you will learn what exam techniques to identify OSD and DED patients, how to counsel patients, and what timing can look like for the acute treatment for rapid rehabilitation and the respective surgeries.
This activity is supported by an unrestricted educational grant from Kala Pharmaceuticals.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Review the prevalence and patient satisfaction impact of dry eye flares in high volume anterior segment surgery/co-management practices
- Discuss the keys for diagnosing signs and symptoms associated with episodic flares of OSD in a high volume setting
- Review case experiences for making therapeutic decisions for patients with variable grades of acute exacerbations of dry eye disease
- Discuss the short and long term outcomes and follow-up regimen for dry eye flare patients
Accreditation
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education LLC (Evolve) and The Fundingsland Group. Evolve is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT
Evolve Medical Education designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Faculty and Disclosures
Elizabeth Yeu, MD
Virginia Eye Consultants
Medical Director, CVP Mid-Atlantic
Cornea, Cataract, External Disease, and Refractive Surgery
Assistant Professor
Department of Ophthalmology
Eastern Virginia Medical School
Norfolk, VA

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Elizabeth Yeu, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Advanced Vision Group, Alcon, Allergan, Avellino, Bausch + Lomb, BioTissue, BVI, BlephEx, Bruder, Carl Zeiss Meditec, CorneaGen, Dompé, Expert Opinion, EyePoint Pharmaceuticals, Glaukos, Guidepoint, Johnson & Johnson Vision, Kala Pharmaceuticals, LayerBio, Lensar, Melt, Merck, Mynosys, Novartis, Ocular Science, Ocusoft, Omeros, Oyster Point Pharmaceuticals, Science Based Health, Sight Sciences, Sun Pharmaceutical Industries, Surface, Tarsus, TearLab, Thea, TopCon, and Visus. Research/Grants: Alcon, BioTissue, Johnson & Johnson Vision, Tarsus, TopCon, and TearLab. Stock/Shareholder: Advanced Vision Group, Avellino, BlephEx, CorneaGen, Expert Opinion, LayerBio, Mati, Melt, Modernizing Medicine, Ocular Science, Orasis, Oyster Point Pharmaceuticals, Staar, Tarsus, and Visus.
The Evolve and The Fundingsland staff and planners have no financial relationships with commercial interests.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group, or Kala Pharmaceuticals.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 01/10/2022
Expiration Date: 01/10/2023

Elizabeth Yeu, MD

Guest

MasterClass: Flares in Pre-Surgical Patients

Recommended

Title